Who can benefit most from popular weight loss drug for obesity and sleep apnea?
Knowridge
A new study has found that some people with obstructive sleep apnea and obesity may benefit much more from the GLP-1 medication tirzepatide than others. Researchers say the findings could help doctors better predict which patients are likely to see the strongest improvements in their sleep apnea symptoms and who may still need additional treatments. […] The post Who can benefit most from popular weight loss drug for obesity and sleep apnea? appeared first on Knowridge Science Report .